Unknown

Dataset Information

Prebiotic inulin ameliorates SARS-CoV-2 infection in hamsters by modulating the gut microbiome.


ABSTRACT: Current treatment options for COVID-19 are limited, with many antivirals and immunomodulators restricted to the most severe cases and preventative care limited to vaccination. As the SARS-CoV-2 virus and its increasing variants threaten to become a permanent fixture of our lives, this new reality necessitates the development of cost-effective and accessible treatment options for COVID-19. Studies have shown that there are correlations between the gut microbiome and severity of COVID-19, especially with regards to production of physiologically beneficial short-chain fatty acids (SCFAs) by gut microbes. In this study, we used a Syrian hamster model to study how dietary consumption of the prebiotic inulin affected morbidity and mortality resulting from SARS-CoV-2 infection. After two weeks of

SUBMITTER: Song I 

PROVIDER: S-EPMC10940623 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature